v3 Template
C

Causaly

Life Sciences / Biotechnology ~20 employees
Founded
--
Employees (Est.)
~20
2 leaders known
Total Funding
$60.0M
Funding Rounds
1
Last Funding
2023-07-13

About Causaly

Causaly is a leading AI platform for life sciences, combining advanced AI, a high-precision knowledge graph, and seamless adoption to help organizations reduce risk and increase R&D productivity at scale. It empowers R&D teams to find, interpret, and share biomedical information with unprecedented precision and efficiency.

Products & Services

Generative AI Copilot:An AI copilot built for scientists to ask complex biomedical questions and receive trustworthy responses with transparent citations.
Knowledge Graph:A high-precision biomedical knowledge graph that distinguishes causality, sorting through millions of data points quickly.
Enterprise Data Fabric:Integrates internal and external data to create a single source of truth for R&D teams, enhancing research continuity.
Scientific RAG:Information retrieval system for life sciences AI, helping teams find relevant information efficiently.
Agentic Research:Science-grade AI designed for R&D processes.
Discover:Enables research workforce scalability.
Bio Graph:Provides access to extensive life sciences knowledge.
Bio Graph API:Allows in-house use of a powerful life sciences knowledge graph for robust analyses.
Pipeline Graph:Combines competitive intelligence with scientific research.

Specialties

Generative AI for Life Sciences Biomedical Knowledge Graphs Target Identification & Prioritization Biomarker Discovery Disease Pathophysiology Indication Expansion Enterprise Data Integration AI-Driven R&D Productivity

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 60000000
MR: -
FA: 60 million
FAN: 60000000
D: 2023-07-13
FD: 2023-07-13
8 investors
Series B Latest
2023-07-13
$60.0M
8 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Y

Yiannis Kiachopoulos

Co-founder & CEO

LinkedIn (Pro only)
A

Artur Saudabayev

Co-founder & CTO

LinkedIn (Pro only)

Recent News

Causaly Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Biotechnology
Company Size
~20 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro